Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$1.7B
Avg Funding
$68.7M
Global Reach
6
countries

Top Cities for Biopharma

Waltham
London
Tsukuba
Cambridge
Victoria
San Mateo

Recently Funded Companies

Export
Waltham, United States

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

$380.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Flip Therapeutics develops in vivo immune cell reprogramming therapies for chronic autoimmune and inflammatory diseases.

$676K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Tsukuba, Japan

SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth (xerostomia) and dry eye conditions.

$7.9M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.

$56.3M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Victoria, Canada

Redefining drug development. Replicating human tissues.

$2.2M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

San Mateo, United States

AusperBio is a biotechnology company focused on developing oligonucleotide therapeutics and targeted delivery technologies.

$120.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Andover, United States

Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.

$1.8M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Axiom Therapeutics is a health tech company that provides computational drug discovery solutions for untreatable cancers.

$12.3M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Radnor, United States

Mitochon Pharmaceuticals is a start-up biotech company.

$1.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Greensboro, United States

LifeCyte Innovations develops therapies targeting chronic inflammation to slow age-related diseases, including AMD and cognitive decline.

$1.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

San Juan, Puerto Rico

MBQ Pharma is a pharmaceutical company that develops a solution for preventing the spread of cancer cells in the body.

$991K raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

$150.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Khartis is a drug discovery company developing oral therapies for immune-mediated and chronic diseases, with a focus on treatments and care.

$50.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

K2 Therapeutics creates advanced antibody-based therapies focused on difficult multi-pass membrane targets to address unmet disease needs.

$50.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Redwood City, United States

Integrated Bio develops multimodal biological datasets and AI for drug discovery, focusing on therapeutics for age-related diseases.

$68.4M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Ratio Therapeutics is a clinical-phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.

$70.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

New York, United States

LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.

$150.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Jersey City, United States

Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.

$118.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Singapore, Singapore

Tikva Allocell is a biotechnology company that specializes in next-gen cell therapies.

$8.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Crystalys Therapeutics is a clinical-stage biopharmaceutical company that develops targeted therapies for gout and hyperuricemia.

$130.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Pike Therapeutics specializes in developing safe and effective cannabinoid formulations with superior drug delivery.

$760K raised
Jul 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Cambrian is a distributed development company building therapeutics to lengthen health span.

$123.8M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Cardiff, United Kingdom

Draig Therapeutics is a clinical-stage biopharmaceutical company that develops investigational therapies for neuropsychiatric disorders.

$65.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Los Altos, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

$100.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease.

$50.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Showing 51 to 75 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$68.7M
Total Funding Tracked
$1.7B
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.London
2 companies$13.0M
2.Cambridge
2 companies$106.3M
3.San Diego
2 companies$180.0M
4.Boston
2 companies$120.0M
5.New York
2 companies$273.8M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

915 Biopharma Startups (2026) — Recently Funded — Page 3 | VCBacked